An orthopedic biomaterial is mainly designed to restore the normal function and properties of impaired tissue.
The global Non-Metal Orthopaedic Biomaterial market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Non-Metal Orthopaedic Biomaterial market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Stryker Corporation
Zimmer Biomet
Johnson & Johnson
Medtronic PLC
Koninklijke DSM
B.Braun
Bayer
Corbion N.V
Evonik Industries
Exactech Inc
Acumed
Globus Medical
SINTX Technologies Inc
Segment by Type
Ceramics
Polylactic Acid
Other
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Non-Metal Orthopaedic Biomaterial report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Âé¶¹Ô´´ Channel and Customer Analysis
Chapter 8: Âé¶¹Ô´´ Opportunities and Challenges
Chapter 9: Âé¶¹Ô´´ Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope of Non-Metal Orthopaedic Biomaterial
1.2 Non-Metal Orthopaedic Biomaterial Segment by Type
1.2.1 Global Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Value Comparison by Type (2023-2029)
1.2.2 Ceramics
1.2.3 Polylactic Acid
1.2.4 Other
1.3 Non-Metal Orthopaedic Biomaterial Segment by Application
1.3.1 Global Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Global Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Non-Metal Orthopaedic Biomaterial Revenue 2018-2029
1.4.2 Global Non-Metal Orthopaedic Biomaterial Sales 2018-2029
1.4.3 Global Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Non-Metal Orthopaedic Biomaterial Sales Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.2 Global Non-Metal Orthopaedic Biomaterial Revenue Âé¶¹Ô´´ Share by Manufacturers (2018-2023)
2.3 Global Non-Metal Orthopaedic Biomaterial Average Price by Manufacturers (2018-2023)
2.4 Global Non-Metal Orthopaedic Biomaterial Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Non-Metal Orthopaedic Biomaterial, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Metal Orthopaedic Biomaterial, Product Type & Application
2.7 Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Competitive Situation and Trends
2.7.1 Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-Metal Orthopaedic Biomaterial Players Âé¶¹Ô´´ Share by Revenue
2.7.3 Global Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-Metal Orthopaedic Biomaterial Retrospective Âé¶¹Ô´´ Scenario by Region
3.1 Global Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Non-Metal Orthopaedic Biomaterial Global Non-Metal Orthopaedic Biomaterial Sales by Region: 2018-2029
3.2.1 Global Non-Metal Orthopaedic Biomaterial Sales by Region: 2018-2023
3.2.2 Global Non-Metal Orthopaedic Biomaterial Sales by Region: 2024-2029
3.3 Global Non-Metal Orthopaedic Biomaterial Global Non-Metal Orthopaedic Biomaterial Revenue by Region: 2018-2029
3.3.1 Global Non-Metal Orthopaedic Biomaterial Revenue by Region: 2018-2023
3.3.2 Global Non-Metal Orthopaedic Biomaterial Revenue by Region: 2024-2029
3.4 North America Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Non-Metal Orthopaedic Biomaterial Sales by Country (2018-2029)
3.4.3 North America Non-Metal Orthopaedic Biomaterial Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Non-Metal Orthopaedic Biomaterial Sales by Country (2018-2029)
3.5.3 Europe Non-Metal Orthopaedic Biomaterial Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Facts & Figures by Country
3.6.1 Asia Pacific Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Non-Metal Orthopaedic Biomaterial Sales by Country (2018-2029)
3.6.3 Asia Pacific Non-Metal Orthopaedic Biomaterial Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Non-Metal Orthopaedic Biomaterial Sales by Country (2018-2029)
3.7.3 Latin America Non-Metal Orthopaedic Biomaterial Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Non-Metal Orthopaedic Biomaterial Sales by Country (2018-2029)
3.8.3 Middle East and Africa Non-Metal Orthopaedic Biomaterial Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Metal Orthopaedic Biomaterial Sales by Type (2018-2029)
4.1.1 Global Non-Metal Orthopaedic Biomaterial Sales by Type (2018-2023)
4.1.2 Global Non-Metal Orthopaedic Biomaterial Sales by Type (2024-2029)
4.1.3 Global Non-Metal Orthopaedic Biomaterial Sales Âé¶¹Ô´´ Share by Type (2018-2029)
4.2 Global Non-Metal Orthopaedic Biomaterial Revenue by Type (2018-2029)
4.2.1 Global Non-Metal Orthopaedic Biomaterial Revenue by Type (2018-2023)
4.2.2 Global Non-Metal Orthopaedic Biomaterial Revenue by Type (2024-2029)
4.2.3 Global Non-Metal Orthopaedic Biomaterial Revenue Âé¶¹Ô´´ Share by Type (2018-2029)
4.3 Global Non-Metal Orthopaedic Biomaterial Price by Type (2018-2029)
5 Segment by Application
5.1 Global Non-Metal Orthopaedic Biomaterial Sales by Application (2018-2029)
5.1.1 Global Non-Metal Orthopaedic Biomaterial Sales by Application (2018-2023)
5.1.2 Global Non-Metal Orthopaedic Biomaterial Sales by Application (2024-2029)
5.1.3 Global Non-Metal Orthopaedic Biomaterial Sales Âé¶¹Ô´´ Share by Application (2018-2029)
5.2 Global Non-Metal Orthopaedic Biomaterial Revenue by Application (2018-2029)
5.2.1 Global Non-Metal Orthopaedic Biomaterial Revenue by Application (2018-2023)
5.2.2 Global Non-Metal Orthopaedic Biomaterial Revenue by Application (2024-2029)
5.2.3 Global Non-Metal Orthopaedic Biomaterial Revenue Âé¶¹Ô´´ Share by Application (2018-2029)
5.3 Global Non-Metal Orthopaedic Biomaterial Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Stryker Corporation
6.1.1 Stryker Corporation Corporation Information
6.1.2 Stryker Corporation Description and Business Overview
6.1.3 Stryker Corporation Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Stryker Corporation Non-Metal Orthopaedic Biomaterial Product Portfolio
6.1.5 Stryker Corporation Recent Developments/Updates
6.2 Zimmer Biomet
6.2.1 Zimmer Biomet Corporation Information
6.2.2 Zimmer Biomet Description and Business Overview
6.2.3 Zimmer Biomet Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Zimmer Biomet Non-Metal Orthopaedic Biomaterial Product Portfolio
6.2.5 Zimmer Biomet Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Johnson & Johnson Non-Metal Orthopaedic Biomaterial Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Medtronic PLC
6.4.1 Medtronic PLC Corporation Information
6.4.2 Medtronic PLC Description and Business Overview
6.4.3 Medtronic PLC Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medtronic PLC Non-Metal Orthopaedic Biomaterial Product Portfolio
6.4.5 Medtronic PLC Recent Developments/Updates
6.5 Koninklijke DSM
6.5.1 Koninklijke DSM Corporation Information
6.5.2 Koninklijke DSM Description and Business Overview
6.5.3 Koninklijke DSM Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Koninklijke DSM Non-Metal Orthopaedic Biomaterial Product Portfolio
6.5.5 Koninklijke DSM Recent Developments/Updates
6.6 B.Braun
6.6.1 B.Braun Corporation Information
6.6.2 B.Braun Description and Business Overview
6.6.3 B.Braun Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.6.4 B.Braun Non-Metal Orthopaedic Biomaterial Product Portfolio
6.6.5 B.Braun Recent Developments/Updates
6.7 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer Non-Metal Orthopaedic Biomaterial Product Portfolio
6.7.5 Bayer Recent Developments/Updates
6.8 Corbion N.V
6.8.1 Corbion N.V Corporation Information
6.8.2 Corbion N.V Description and Business Overview
6.8.3 Corbion N.V Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Corbion N.V Non-Metal Orthopaedic Biomaterial Product Portfolio
6.8.5 Corbion N.V Recent Developments/Updates
6.9 Evonik Industries
6.9.1 Evonik Industries Corporation Information
6.9.2 Evonik Industries Description and Business Overview
6.9.3 Evonik Industries Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Evonik Industries Non-Metal Orthopaedic Biomaterial Product Portfolio
6.9.5 Evonik Industries Recent Developments/Updates
6.10 Exactech Inc
6.10.1 Exactech Inc Corporation Information
6.10.2 Exactech Inc Description and Business Overview
6.10.3 Exactech Inc Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Exactech Inc Non-Metal Orthopaedic Biomaterial Product Portfolio
6.10.5 Exactech Inc Recent Developments/Updates
6.11 Acumed
6.11.1 Acumed Corporation Information
6.11.2 Acumed Non-Metal Orthopaedic Biomaterial Description and Business Overview
6.11.3 Acumed Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Acumed Non-Metal Orthopaedic Biomaterial Product Portfolio
6.11.5 Acumed Recent Developments/Updates
6.12 Globus Medical
6.12.1 Globus Medical Corporation Information
6.12.2 Globus Medical Non-Metal Orthopaedic Biomaterial Description and Business Overview
6.12.3 Globus Medical Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Globus Medical Non-Metal Orthopaedic Biomaterial Product Portfolio
6.12.5 Globus Medical Recent Developments/Updates
6.13 SINTX Technologies Inc
6.13.1 SINTX Technologies Inc Corporation Information
6.13.2 SINTX Technologies Inc Non-Metal Orthopaedic Biomaterial Description and Business Overview
6.13.3 SINTX Technologies Inc Non-Metal Orthopaedic Biomaterial Sales, Revenue and Gross Margin (2018-2023)
6.13.4 SINTX Technologies Inc Non-Metal Orthopaedic Biomaterial Product Portfolio
6.13.5 SINTX Technologies Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Metal Orthopaedic Biomaterial Industry Chain Analysis
7.2 Non-Metal Orthopaedic Biomaterial Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Metal Orthopaedic Biomaterial Production Mode & Process
7.4 Non-Metal Orthopaedic Biomaterial Sales and Âé¶¹Ô´´ing
7.4.1 Non-Metal Orthopaedic Biomaterial Sales Channels
7.4.2 Non-Metal Orthopaedic Biomaterial Distributors
7.5 Non-Metal Orthopaedic Biomaterial Customers
8 Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Dynamics
8.1 Non-Metal Orthopaedic Biomaterial Industry Trends
8.2 Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Drivers
8.3 Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Challenges
8.4 Non-Metal Orthopaedic Biomaterial Âé¶¹Ô´´ Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Stryker Corporation
Zimmer Biomet
Johnson & Johnson
Medtronic PLC
Koninklijke DSM
B.Braun
Bayer
Corbion N.V
Evonik Industries
Exactech Inc
Acumed
Globus Medical
SINTX Technologies Inc
Ìý
Ìý
*If Applicable.